Company: BKYI
Filing Date: 2025-04-23
Form Type: 10-K
Source: 0001437749-25-012824
Chunk: 60

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-04-23
Form: 10-K
Item: Item 1A
Chunk 60
---
  $1,316,014 
 Accrued liabilities   1,278,732   1,305,848 
 Note payable   1,525,977   - 
 Government loan – BBVA Bank, current portion   132,731   138,730 
 Deferred revenue - current   773,267   414,968 
 Operating lease liabilities, current portion   24,642   37,829 
 Total current liabilities   4,553,536   3,213,389 
 Deferred revenue, net of current portion   196,237   28,296 
 Deferred tax liability   -   22,998 
 Government loan – BBVA Bank, net of current portion   44,762   188,787 
 Operating lease liabilities, net of current portion   48,994   - 
 Total non-current liabilities   289,993   240,081 
 TOTAL LIABILITIES   4,843,529   3,453,470 
         
 Commitments (Note O)           
         
 STOCKHOLDERS’ EQUITY         
 Common stock — authorized, 170,000,000 shares; issued and outstanding; 3,715,483 and 1,032,777 of $.0001 par value at December 31, 2024 and December 31, 2023, respectively   372   103 
 Additional paid-in capital   133,030,271   126,047,851 
 Accumulated other comprehensive loss   49,290   22,821 
 Accumulated deficit   (129,307,902)  (125,007,210)
 TOTAL STOCKHOLDERS’ EQUITY   3,772,031   1,063,565 
 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $8,615,560  $4,517,035 

All BIO-key shares issued and outstanding for all periods reflect BIO-key’s 1-for-18 reverse stock split, which was effective December 21, 2023.

The accompanying notes are an integral part of these statements.

    42

BIO-key International, Inc. and Subsidiaries

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

       2024 

       2023 

       Revenues 

       Services